Diurnal variation in platelet inhibition by clopidogrel.

Abstract:

:Morning increase in the occurrence of myocardial infarction, stroke and sudden cardiac death is a well-recognized phenomenon, which is in line with a morning enhancement of platelet aggregation. We investigated whether platelet inhibition during clopidogrel and aspirin therapy varies during the day. Fifty-nine consecutive patients (45 men and 14 women) with first ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary interventions (pPCI) on dual antiplatelet therapy were prospectively enrolled into the study. Blood samples were collected 4 days after start of clopidogrel treatment at 6.00 a.m., 10.00 a.m., 2.00 p.m. and 7.00 p.m. Arachidonic acid and adenosine diphosphate (ADP)-induced platelet aggregation were assessed by impedance aggregometry. Platelet inhibition by clopidogrel was lowest in the midmorning: median ADP-induced platelet aggregation was 55%, 17% and 27% higher at 10.00 a.m. compared to 6.00 a.m., 2.00 p.m. and 7.00 p.m., respectively (p < 0.002). Nonresponsiveness to clopidogrel defined according to the device manufacturer was 2.4-fold more frequent in the midmorning than in the early morning. We observed a more pronounced midmorning increase in ADP-induced platelet aggregation in diabetic patients when compared to non-diabetics. In contrast, no diurnal variation in the antiplatelet effect of aspirin was observed. In conclusion, in patients presenting with STEMI undergoing pPCI, platelet inhibition by clopidogrel is less strong in the midmorning hours. This periodicity in platelet aggregation in patients on dual antiplatelet therapy should be taken into consideration when assessing platelet function in clinical studies.

journal_name

Platelets

journal_title

Platelets

authors

Kozinski M,Bielis L,Wisniewska-Szmyt J,Boinska J,Stolarek W,Marciniak A,Kubica A,Grabczewska Z,Navarese EP,Andreotti F,Siller-Matula JM,Rosc D,Kubica J

doi

10.3109/09537104.2011.582900

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

579-87

issue

8

eissn

0953-7104

issn

1369-1635

journal_volume

22

pub_type

杂志文章
  • Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis.

    abstract::Autophagy is an effective strategy for cell development by recycling cytoplasmic constituents. Genetic deletion of autophagy mediator Atg7 in hematopoietic stem cells (HSCs) can lead to failure of megakaryopoiesis and enhanced autophagy has been implicated in various hematological disorders such as immune thrombocytop...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2016.1204436

    authors: Wang Q,You T,Fan H,Wang Y,Chu T,Poncz M,Zhu L

    更新日期:2017-01-01 00:00:00

  • Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.

    abstract::Clopidogrel is a second-generation thienopyridine that irreversibly inhibits the P2Y(12) adenosine diphosphate (ADP) receptor on platelets, preventing platelet aggregation. As early as 2003, researchers have observed inter-patient variability in response to clopidogrel, leading to a multitude of studies investigating ...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.3109/09537100903261379

    authors: Vila PM,Zafar MU,Badimon JJ

    更新日期:2009-12-01 00:00:00

  • Tityus discrepans scorpion venom activates platelets through GPVI and a novel Src-dependent signaling pathway.

    abstract::In humans and other mammals, Tityus discrepans (Td) scorpion envenomation produces a variety of systemic effects including respiratory distress, a generalized inflammatory reaction, modulation of blood pressure, fibrin formation, and platelet activation. For many of these effects, the venom components and underlying m...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2010.544343

    authors: Brazón J,Hughes CE,Mori J,Sevcik C,D'suze G,Watson SP

    更新日期:2011-01-01 00:00:00

  • Effects of malondialdehyde content in low density lipoproteins on platelet adhesion.

    abstract::Platelets play a key role in thrombotic vascular occlusion at the side of an atherosclerotic plaque. Malondialdehyde (MDA) derivatives are components of oxidized LDL. Recent studies suggest enhanced adhesion of platelets on oxidized LDL, but evidence of MDA-modified LDL contribution to enhanced platelet adhesion is mi...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100500261590

    authors: Suttnar J,Otáhalová E,Cermák J,Dyr JE

    更新日期:2006-03-01 00:00:00

  • Prostaglandin Regulation of Cyclic AMP Metabolism in Human Platelets.

    abstract::Prostaglandins stimulate cyclic AMP synthesis in platelets, leading to inhibition of platelet aggregation. Prostaglandin receptors have been identified but knowledge of their pharmacology is limited by the lack of antagonists. Kinetic measurements of prostaglandinregulated cyclic AMP formation provide useful informati...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109009009190

    authors: Ashby B

    更新日期:1990-01-01 00:00:00

  • Diurnal variations in tissue factor and tissue factor pathway inhibitor concentrations in relation to on-treatment platelet reactivity: an analysis of patients with acute myocardial infarction.

    abstract::The aim of the study was to evaluate diurnal changes of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) concentrations in relation to on-treatment platelet reactivity. The study group included 51 patients with acute myocardial infarction (AMI) treated with primary percutaneous coronary intervention and d...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2019.1693037

    authors: Boinska J,Koziński M,Kasprzak M,Ziołkowska K,Dziembowska I,Ziołkowski M,Kubica J,Rość D

    更新日期:2020-10-02 00:00:00

  • Platelet aggregation in erythropoietin treated dialysis patients.

    abstract::Recombinant human erythropoietin is a successful treatment for the anaemia of renal failure. Its use has however been associated with thromboembolic complications. Changes in platelet number and behaviour in vitro were studied in: (1) 23 haemodialysis patients, and 10 continuous ambulatory peritoneal dialysis patients...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109209013168

    authors: Taylor JE,Henderson IS,Stewart WK,Belch JJ

    更新日期:1992-01-01 00:00:00

  • Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.

    abstract::Activated platelets serve as a catalyst for thrombin generation and a source of vasoactive and mitogenic factors affecting vascular remodeling. Oral menopausal hormone treatments (MHT) may carry greater thrombotic risk than transdermal products. This study compared effects of oral and transdermal MHT on platelet chara...

    journal_title:Platelets

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.3109/09537104.2015.1023273

    authors: Miller VM,Lahr BD,Bailey KR,Heit JA,Harman SM,Jayachandran M

    更新日期:2016-01-01 00:00:00

  • Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin.

    abstract::The typical data presentation by flow cytometry of platelet suspensions stimulated with calcium ionophore A-23187, thrombin, C5b-9, or other agonists shows a unimodal decrease (or 'left-shift') in forward angle light scatter. Many reports in the literature interpret these findings as indicative of the appearance of sm...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100050129279

    authors: Bode AP,Hickerson DH

    更新日期:2000-08-01 00:00:00

  • Reduced antioxidant capacities in platelets from patients with autoimmune thrombocytopenia purpura (ITP).

    abstract::Autoimmune thrombocytopenic purpura (ITP) is characterized by an abnormally low platelet count and bleeding risks. The exact triggering event remains elusive. Oxidative stress may play a role in several autoimmune diseases. A direct link between platelets in ITP and oxidative stress has not yet been addressed. The int...

    journal_title:Platelets

    pub_type: 临床试验,杂志文章

    doi:10.3109/09537104.2011.610909

    authors: Kamhieh-Milz J,Bal G,Sterzer V,Kamhieh-Milz S,Arbach O,Salama A

    更新日期:2012-01-01 00:00:00

  • A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model.

    abstract::D-glucono-1,4-lactone, sodium D-gluconate and calcium D-glucarate are non-toxic glucose derivatives occurring naturally in fruits and vegetables. Calcium D-glucarate is promoted as an orally bioavailability dietary supplement with potential chemopreventive activity without adverse effects. Despite many commercial appl...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2010.512210

    authors: Saluk-Juszczak J

    更新日期:2010-01-01 00:00:00

  • Aging of platelets stored for transfusion.

    abstract::A goal of platelet storage is to maintain the quality of platelets from the point of donation to the point of transfusion - to suspend the aging process. This effort is judged by clinical and laboratory measures with varying degrees of success. Recent work gives encouragement that platelets can be maintained ex vivo b...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.3109/09537104.2016.1171303

    authors: Smethurst PA

    更新日期:2016-09-01 00:00:00

  • Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.

    abstract::Extracellular matrix metalloproteinase inducer (EMMPRIN; CD147), which binds to the platelet-specific collagen receptor glycoprotein (GP) VI, is expressed in a range of cell types including platelets and leukocytes, and has been implicated in neoplastic disease and atherosclerotic coronary disease. Both CD147 and GPVI...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2013.852660

    authors: Pennings GJ,Yong AS,Wong C,Al-Tamimi M,Gardiner EE,Andrews RK,Kritharides L

    更新日期:2014-01-01 00:00:00

  • Original article: relaxin reduces the number of circulating platelets and depresses platelet release from megakaryocytes: studies in rats.

    abstract::In previous studies we have shown that relaxin (RLX), a peptide hormone produced predominantly during pregnancy, is a powerful inhibitor of platelet aggregation. The current study shows that RLX, given systemically to rats, also affects the number of circulating platelets and their release by spleen megakaryocytes. Ma...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109509078467

    authors: Bani D,Maurizi M,Bigazzi M

    更新日期:1995-01-01 00:00:00

  • Time dependent reduction in platelet aggregation using the multiplate analyser and hirudin blood due to platelet clumping.

    abstract::The Multiplate is a popular instrument that measures platelet function using whole blood. Potentially considered a point of care instrument, it is also used by hemostasis laboratories. The instrument is usually utilized to assess antiplatelet medication or as a screen of platelet function. According to the manufacture...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2017.1384540

    authors: Chapman K,Favaloro EJ

    更新日期:2018-05-01 00:00:00

  • The cellular basis of platelet secretion: Emerging structure/function relationships.

    abstract::Platelet activation has long been known to be accompanied by secretion from at least three types of compartments. These include dense granules, the major source of small molecules; α-granules, the major protein storage organelle; and lysosomes, the site of acid hydrolase storage. Despite ~60 years of research, there a...

    journal_title:Platelets

    pub_type: 杂志文章,评审

    doi:10.1080/09537104.2016.1257786

    authors: Yadav S,Storrie B

    更新日期:2017-03-01 00:00:00

  • Human platelet lysates for human cell propagation.

    abstract::A pathogen-free and standardized xeno-free supplement of growth media is required for the ex vivo propagation of human cells used as advanced therapeutic medicinal products and for clinical translation in regenerative medicine and cell therapies. Human platelet lysate (HPL) made from therapeutic-grade platelet concent...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2020.1849602

    authors: Barro L,Burnouf PA,Chou ML,Nebie O,Wu YW,Chen MS,Radosevic M,Knutson F,Burnouf T

    更新日期:2020-11-29 00:00:00

  • Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?

    abstract::Platelets in flowing blood at high-shear stress are recruited to exposed subendothelial collagen of injured vessels by GPIb-von Willebrand factor (vWf) and integrin alpha(2)beta(1) (alpha(2)beta(1))-collagen interactions. Platelet adhesion to type I collagen depends mainly on the alpha(2)beta(1)-collagen interaction a...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537100903497549

    authors: Jung SM,Sonoda M,Tsuji K,Jimi A,Nomura S,Kanaji T,Moroi M

    更新日期:2010-01-01 00:00:00

  • Medium on-treatment platelet reactivity to ADP is favorable in patients with acute coronary syndromes undergoing coronary stenting.

    abstract::Bleeding in the setting of acute coronary syndromes (ACS) has negative prognostic implications. We sought to determine the impact of different levels of on-treatment platelet reactivity (PR) to ADP on both bleeding and ischemic events in ACS patients receiving coronary stenting. PR to ADP was measured with the VerifyN...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2011.568075

    authors: Huczek Z,Filipiak KJ,Kochman J,Michalak M,Roik M,Grabowski M,Opolski G

    更新日期:2011-01-01 00:00:00

  • Factor VIII is a positive regulator of platelet function.

    abstract::FVIII is an important cofactor in the tenase coagulation factor complex, lack of FVIII causes severe bleeding, whereas high FVIII levels seem to be associated with venous and arterial thromboembolism. Resting platelets do not bind FVIII, but activated platelets bind unactivated FVIII if vWF is not present. We investig...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537100600747035

    authors: Obergfell A,Sturm A,Speer CP,Walter U,Grossmann R

    更新日期:2006-11-01 00:00:00

  • Efficacy and safety of different ticagrelor regimens versus clopidogrel in patients with coronary artery disease: a retrospective multicenter study (SUPERIOR).

    abstract::Current guidelines favor dual anti-platelet therapy with ticagrelor 90 mg BID (T90BID) over clopidogrel 75 mg QD (C75QD) in addition to aspirin for acute coronary syndrome. However, an increased risk of ticagrelor-related adverse events prompted the evaluation of low-dose regimens. This study (NCT03381742) retrospecti...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2020.1732328

    authors: Shi J,He M,Wang W,Liu G,Zhang H,Sun D,Li J,Mu H,Xu M,Zhao C,Wang J,Zhang C,Cang H,Zhao S,Zhang Z,Li Y

    更新日期:2021-01-02 00:00:00

  • Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients.

    abstract::Selected aspirin treated patients may exhibit high platelet reactivity to agonists other than arachidonic acid. This study aimed to determine whether the VerifyNow identifies generalized high platelet reactivity supported by correlations with other established methods that stimulate platelets with various agonists. St...

    journal_title:Platelets

    pub_type: 杂志文章,随机对照试验

    doi:10.1080/09537100701206824

    authors: Dichiara J,Bliden KP,Tantry US,Chaganti SK,Kreutz RP,Gesheff TB,Kreutz Y,Gurbel PA

    更新日期:2007-09-01 00:00:00

  • Risk factors and clinical outcome of profound thrombocytopenia in adult patients with DENV infections.

    abstract::Severe thrombocytopenia is common in dengue virus (DENV) infections. However, studies focusing on the role of profound thrombocytopenia (PT) (nadir platelet counts ≤ 20 000/mm3) in DENV infections are scarce. This study aims to identify the associated features and outcome of DENV patients with PT. It involves 237 adul...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537104.2017.1293802

    authors: Dhanoa A,Rajasekaram G,Hassan SS,Ramadas A,Azreen Adnan NA,Lau CF,Chan TS,Ngim CF

    更新日期:2017-11-01 00:00:00

  • Lipoxygenase product controls the regulatory volume decrease of human platelets.

    abstract::SUMMARY. Blood platelets exposed to hypotonic medium are known to undergo a regulatory volume decrease (RVD), mediated by increased conductive permeability of K(+) and Cl(-). It is presently shown that RVD in platelets is controlled by a lipoxygenase product, apparently by a selective regulation of K(+) permeability. ...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109109005512

    authors: Margalit A,Livne AA

    更新日期:1991-01-01 00:00:00

  • Response of blood platelets to resveratrol.

    abstract::The phytochemical resveratrol (3,4',5-trihydroxystilbene), which is found in grapes and wine, has been reported to have a variety of anti-inflammatory, anti-platelet and anti-carcinogenic effects. The aim of the present study was to evaluate the effects of trans-resveratrol on adhesion of blood platelets to collagen, ...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537109976103

    authors: Zbikowska HM,Olas B,Wachowicz B,Krajewski T

    更新日期:1999-07-01 00:00:00

  • Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors.

    abstract::Platelets are involved in host defense via clearance of bacteria from the circulation, interaction with virus particles, and uptake of various size particulates. There is a growing interest in micro- and nanoparticles for drug delivery and there is evidence that the properties of these particles critically influence t...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2012.703792

    authors: Gupalo E,Kuk C,Qadura M,Buriachkovskaia L,Othman M

    更新日期:2013-01-01 00:00:00

  • Assessment of the platelet parameters and serum butyrylcholinesterase activity in type 1 diabetes patients with ketoacidosis.

    abstract::The potential roles of serum butyrylcholinesterase (BChE) activity and platelet indices in type 1 diabetes (T1D) remain uncertain. We aimed to investigate the correlation among the platelet indices, serum BChE activity, and diabetic ketoacidosis (DKA). Sixty-one T1D patients, 29 patients with DKA, and 30 age- and sex-...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537104.2012.735720

    authors: Ma SG,Yang LX,Qiu XQ

    更新日期:2013-01-01 00:00:00

  • The relationship of platelet count, mean platelet volume with metabolic syndrome according to the criteria of the American Association of Clinical Endocrinologists: a focus on gender differences.

    abstract::Metabolic syndrome (MS) is becoming globally prevalent and it is clinically important because of its association with type 2 diabetes and cardiovascular disease, and some cancers. Recently, platelet count has been linked to insulin resistance and MS in addition to being a marker of hemostasis. Also, mean platelet volu...

    journal_title:Platelets

    pub_type: 临床试验,杂志文章

    doi:10.3109/09537104.2011.589014

    authors: Park BJ,Shim JY,Lee HR,Jung DH,Lee JH,Lee YJ

    更新日期:2012-01-01 00:00:00

  • Release of Choline Metabolites from Human Platelets: Evidence for Activation of Phospholipase D and of Phosphatidylcholine-specific Phospholipase C.

    abstract::In aspirin-treated platelets labelled by preincubation with [(3)H]-choline, enhanced release of both [(3)H]-choline and [(3)H]-choline phosphate resulted from stimulation by collagen or thrombin. No such release accompanied stimulation by ADP, platelet-activating factor or adrenaline. Release of [(3)H]-choline phospha...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.3109/09537109309013192

    authors: Petty AC,Scrutton MC

    更新日期:1993-01-01 00:00:00

  • Cytokines, platelet production and hemostasis.

    abstract::A number of hematopoietic growth factors and other cytokines are capable of altering platelet production and function. Enhancement of these processes may be exploited to ameliorate bleeding propensity in thrombocytopenic patients. Under certain circumstances, cytokines may have adverse effects on the hemostatic system...

    journal_title:Platelets

    pub_type: 杂志文章

    doi:10.1080/09537109709169324

    authors: Burstein SA

    更新日期:1997-01-01 00:00:00